Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains EqualWeight Rating for Hershey with Increased Price Target

Elaine Mendonca by Elaine Mendonca
February 9, 2024
in Breaking News
0
Food Retailers Stock Market Today
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On February 9, 2024, Chris Carey, an analyst from Wells Fargo, expressed his view on Hershey (NYSE:HSY). He maintained an “Equal-Weight” rating for the company but increased the price target from $190 to $210. This indicates that Carey believes the stock is reasonably valued at its current price and anticipates it to reach $210 in the future. It’s crucial to acknowledge that price targets can differ among analysts. In the case of Hershey, the average one-year price target stands at $222.31, with projections ranging from as low as $180 to as high as $325.50.

Hershey Company (HSY) Stock Performance Declines: Potential Bearish Trend Amidst Weak Financial Results and Increased Competition

On February 9, 2024, Hershey Company (HSY) experienced a decline in its stock performance. The price of HSY shares dropped by $4.07 since the market last closed, representing a decrease of 2.01%. HSY opened the trading day at $201.12, which was $1.19 lower than its previous close. Trading near the bottom of its 52-week range and below its 200-day simple moving average suggests a potential bearish trend for HSY. Factors such as weak financial results, increased competition, and changes in consumer preferences could be contributing to this poor performance. Investors and analysts will closely monitor HSY’s stock performance in the coming days to determine if the decline is a short-term correction or a sustained trend. Thorough research and analysis are essential for making informed investment choices.

Hershey Company (HSY) Reports Positive Revenue and Net Income Growth, but Fourth Quarter Raises Concerns

On February 9, 2024, Hershey Company (HSY) reported its financial results for the past year and the fourth quarter. The data provides insights into the company’s total revenue, net income, and earnings per share (EPS) performance. Let’s analyze the figures to understand HSY’s stock performance.

Total Revenue:
HSY’s total revenue for the past year stood at $11.16 billion, representing a 7.16% increase compared to the previous year. However, the company experienced a decline in total revenue in the fourth quarter, reporting $2.66 billion, which is a 12.31% decrease compared to the previous quarter.

Net Income:
HSY’s net income for the past year was $1.86 billion, reflecting a 13.19% increase compared to the previous year. In the fourth quarter, the net income held flat at $349.04 million, indicating no significant change compared to the previous quarter.

Earnings per Share (EPS):
HSY reported earnings per share (EPS) of $9.06 for the past year, representing a 13.79% increase compared to the previous year. However, in the fourth quarter, the EPS decreased to $1.70, reflecting a significant 32.64% decline compared to the previous quarter.

In conclusion, HSY’s stock performance on February 9, 2024, shows a positive trend in terms of total revenue and net income growth over the past year. However, the decline in total revenue and EPS during the fourth quarter suggests potential challenges faced by the company during that period. Investors should carefully analyze these figures and consider other factors before making any investment decisions regarding HSY stock.

Tags: HSY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Potential Merger Talks Resume Between Grab and GoTo in Southeast Asian Food Delivery Market

Gas Utilities Markets and money

Duke Energy Receives Positive Outlook from Wells Fargo Analyst

Healthcare Services Stock Exchange

Dexcom Inc Reports Impressive Financial Results and Promising Outlook for Continuous Glucose Monitoring

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com